None listed
Conditions
Interventions
L-Dex group: 0.1ug/ml dexmedetomidine+0.08% ropivacaine:Epidural application
H-Dex group: 0.2ug/ml dexmedetomidine+0.08% ropivacaine:Epidural application
SF group: 0.25ug/ml sufentanil+0.08% ropivacaine:Epidural application
Sponsors
Shanghai 10th People's Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: 1. Full term primiparous expectant mothers; 2. Age 20-35 years old; 3. Fetal absence of complications such as intrauterine distress, amniotic fluid contamination, cephalopelvic imbalance, and intrauterine infection; 4. All sign informed consent forms; 5. Willing to follow research requirements
Exclusion criteria
Exclusion criteria: 1. Pregnant women with concomitant mental illness, cardiovascular and other important organ diseases; 2. Pregnant women without postoperative pain relief requirements; 3. There are contraindications for spinal anesthesia; 4. Opioid drug addicts; 5. Pregnant women with abnormal fetal heart rate monitoring (fetal heart rate>160 beats/minute or<120 beats/minute, lasting for 10 minutes)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| body temperature;epidural anesthesia block level;Improved Bromage rating;blood pressure;heart rate;Rate of vaginal delivery to cesarean section;Duration of the first stage of labor;Second stage of labor duration;Duration of the third stage of labor;The analgesic duration;Neonatal Apgar score;Perceived blockade score;Adverse reactions; | — |
Countries
China
Contacts
Public ContactNiu Xiaoyin
Shanghai 10th People's Hospital
Outcome results
None listed